|
2022 Other Outputs New peptide comprising specified amino acid sequence useful for treating or preventing inflammatory or autoimmune condition including inflammatory bowel disease, asthma, rheumatoid arthritis and celiac disease.Cobos, C., Daly, N., Loukas, A., Bansal, P., Toth, I. and Skwarczynski, M. (2022). New peptide comprising specified amino acid sequence useful for treating or preventing inflammatory or autoimmune condition including inflammatory bowel disease, asthma, rheumatoid arthritis and celiac disease. . WO2022120423. |
|
2021 Other Outputs Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA AssayShalash, Ahmed O., Azuar, Armira, Madge, Harrison Y. R., Modhiran, Naphak, Amarilla, Alberto A., Liang, Benjamin, Khromykh, Alexander, Watterson, Daniel, Young, Paul R., Toth, Istvan and Skwarczynski, Mariusz (2021). Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay. doi: 10.21203/rs.3.pex-1559/v1 |
|
2002 Other Outputs A multiple antigen lipophilic adjuvant carrier system (MALAC)Toth, I., Horvath, A., Good, M. F. and Olive, C. (2002). A multiple antigen lipophilic adjuvant carrier system (MALAC). Australian Provisional PS2233. |
|
2002 Other Outputs Charged liposaccarides for drug deliveryToth, I. and Falconer, R. A. (2002). Charged liposaccarides for drug delivery. UK-0100115.5; WO2002-AUS-20020103. |
|
2001 Other Outputs Protected aminosugarsToth, I., Dekany, G. and Kellam, B. (2001). Protected aminosugars. 730910. |
|
2001 Other Outputs Oligosaccharide synthesisToth, I., Dekany, G. and Kellam, B. (2001). Oligosaccharide synthesis. 728149. |
